Stock NAUT NAUTILUS BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
2.69 USD +0.75% Intraday chart for Nautilus Biotechnology, Inc. +8.03% -10.03%
Apr. 30 Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30 Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Goldman Sachs Halves Price Target on Nautilus Biotechnology to $2 From $4 Amid Product Launch Delay; Neutral Rating Kept
MT
Morgan Stanley Lowers Nautilus Biotechnology's Price Target to $6 From $8, Maintains Equalweight Rating
MT
Goldman Sachs Adjusts Nautilus Biotechnology's Price Target to $4 from $5, Keeps Neutral Rating
MT
Goldman Sachs Adjusts Nautilus Biotechnology's Price Target to $5 from $9, Keeps Neutral Rating
MT
Morgan Stanley Initiates Nautilus Biotechnology at Equalweight With $8 Price Target, Sees Commercialization Key to Unlocking Upside
MT
Cowen Initiates Coverage on Nautilus Biotechnology With Outperform Rating
MT
NAUTILUS BIOTECHNOLOGY : Goldman Sachs Starts Nautilus Biotechnology at Neutral With $10 Price Target
MT
NAUTILUS BIOTECHNOLOGY : Jefferies Starts Nautilus Biotechnology at Buy With $13 Price Target
MT
NAUTILUS BIOTECHNOLOGY : Jefferies Initiates Coverage on Nautilus Biotechnology With Buy Rating, $13 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAUT Stock
  4. News Nautilus Biotechnology, Inc.
  5. Analyst Reco.